Literature DB >> 3947141

Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation.

A J Tingle, M Allen, R E Petty, G D Kettyls, J K Chantler.   

Abstract

Joint manifestations observed during the course of a prospective RA 27/3 rubella immunisation trial were compared with those observed during an intercurrent wild rubella epidemic in an outlying community. Among 44 rubella haemagglutination inhibition (HAI) negative females ranging in age from 17 to 33 years who received rubella vaccine, six (13.6%) developed acute polyarticular arthritis within two to four weeks postvaccine and two (4.5%) had continuing or recurrent arthropathy lasting longer than 18 months. In contrast, among 23 females ranging in age from 11 to 39 years undergoing wild rubella infection, 12 (52.2%) developed acute polyarticular arthritis and seven (30.4%) had recurrent arthropathy 18 months postinfection. Among 23 males ranging in age from 13 to 54 years undergoing wild rubella infection, only two (8.7%) developed acute arthritis and both individuals had continuing joint manifestations 18 months postinfection. Wild rubella infection in adult populations is associated with a higher incidence, increased severity, and more prolonged duration of joint manifestations than is seen after RA 27/3 rubella immunisation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947141      PMCID: PMC1001829          DOI: 10.1136/ard.45.2.110

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  New Japanese rubella vaccine: comparative trials.

Authors:  J M Best; J E Banatvala; J M Bowen
Journal:  Br Med J       Date:  1974-07-27

2.  Rubella virus. Isolation, characterization, and laboratory diagnosis.

Authors:  P D Parkman; H E Hopps; H M Meyer
Journal:  Am J Dis Child       Date:  1969-07

3.  Rubella vaccine trials in adults and children. Comparison of three attenuated vaccines.

Authors:  J A Dudgeon; W C Marshall; C S Peckham
Journal:  Am J Dis Child       Date:  1969-08

4.  Vaccination of adults with Wistar RA 27/3 rubella vaccine.

Authors:  D S Freestone; J Prydie; S G Smith; G Laurence
Journal:  J Hyg (Lond)       Date:  1971-09

5.  Comparative trials of RA 27-3 and Cendehill rubella vaccines in adult and adolescent females.

Authors:  A Fogel; A Moshkowitz; L Rannon; C B Gerichter
Journal:  Am J Epidemiol       Date:  1971-05       Impact factor: 4.897

6.  Arthritis associated with induced rubella infection.

Authors:  P L Ogra; J K Herd
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

7.  Persistent rubella infection and rubella-associated arthritis.

Authors:  J K Chantler; D K Ford; A J Tingle
Journal:  Lancet       Date:  1982-06-12       Impact factor: 79.321

8.  Studies on vaccine-induced rubella arthritis. Serologic findings before and after immunization.

Authors:  A J Tingle; G D Kettyls; D K Ford
Journal:  Arthritis Rheum       Date:  1979-04

9.  Prospective immunological assessment of arthritis induced by rubella vaccine.

Authors:  A J Tingle; T Yang; M Allen; G D Kettyls; R P Larke; M Schulzer
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Chronic arthropathy associated with rubella vaccination.

Authors:  S L Spruance; R Metcalf; C B Smith; M M Griffiths; J R Ward
Journal:  Arthritis Rheum       Date:  1977-03
View more
  29 in total

Review 1.  Drug-induced rheumatic disorders: incidence, prevention and management.

Authors:  P Vergne; P Bertin; C Bonnet; C Scotto; R Trèves
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

Review 2.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Preventive health examinations.

Authors:  M Russell; H Bryant
Journal:  Can Fam Physician       Date:  1988-12       Impact factor: 3.275

Review 4.  A literature review on the patients with autoimmune diseases following vaccination against infections.

Authors:  Yan Liang; Fan-Ya Meng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 5.  Rubella in the United States: toward a strategy for disease control and elimination.

Authors:  K L Herrmann
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

Review 6.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

7.  Sequence variation in 5' termini of rubella virus genomes: changes affecting structure of the 5' proximal stem-loop.

Authors:  P Johnstone; J E Whitby; T Bosma; J M Best; P G Sanders
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Mapping of genetic determinants of rubella virus associated with growth in joint tissue.

Authors:  K D Lund; J K Chantler
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine.

Authors:  C M Benjamin; G C Chew; A J Silman
Journal:  BMJ       Date:  1992-04-25

10.  Cellular hyperimmunoreactivity to rubella virus synthetic peptides in chronic rubella associated arthritis.

Authors:  L A Mitchell; D Décarie; R Shukin; A J Tingle; D K Ford; M Lacroix; M Zrein
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.